Point72 Europe’s Bio-Techne TECH Stock Holding History

Point72 Europe’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-65,961	Closed	-$4.73M	–	180
2024 Q2	$4.73M	Buy	65,961 +8,700	+15%	+$640K	0.39%	84
2024 Q1	$4.03M	Buy	+57,261	New	+$4.1M	0.36%	86

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Point72 Europe's TECH Position: Q3 2024 in Review

Point72 Europe sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 65,961 shares — an estimated $4.73M sold.

Point72 Europe first reported a position in TECH in Q1 2024 and held it in 2 quarters. The position peaked at $4.73M in Q2 2024. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

Point72 Europe reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
Point72 Europe sold 65,961 Bio-Techne shares in Q3 2024, an estimated $4.73M.
Point72 Europe first reported a position in Bio-Techne in Q1 2024 and held it in 2 quarters.
Point72 Europe's Bio-Techne position peaked at $4.73M in Q2 2024.
562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Point72 Europe's 13F filing for Q3 2024, filed 14 Nov 2024.